Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Dániel Erdélyi:

Pharmacogenetics of anthracyclines. Sági JC et al. Pharmacogenomics. (2016)

[Epigenetic effects affecting etoposide distribution and metabolism in the human body]. Kovács ER et al. Orv Hetil. (2018)

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma. Hegyi M et al. Oncotarget. (2017)

Search results

Items: 1 to 20 of 27

1.

Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.

Rzepiel A, Kutszegi N, Gézsi A, Sági JC, Egyed B, Péter G, Butz H, Nyírő G, Müller J, Kovács GT, Szalai C, Semsei ÁF, Erdélyi DJ.

J Transl Med. 2019 Nov 14;17(1):372. doi: 10.1186/s12967-019-2114-x.

2.

[Epigenetic effects affecting etoposide distribution and metabolism in the human body].

Kovács ER, Tóth S, Erdélyi DJ.

Orv Hetil. 2018 Aug;159(32):1295-1302. doi: 10.1556/650.2018.31162. Review. Hungarian.

PMID:
30078355
3.

Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.

Sági JC, Egyed B, Kelemen A, Kutszegi N, Hegyi M, Gézsi A, Herlitschke MA, Rzepiel A, Fodor LE, Ottóffy G, Kovács GT, Erdélyi DJ, Szalai C, Semsei ÁF.

BMC Cancer. 2018 Jul 3;18(1):704. doi: 10.1186/s12885-018-4629-6.

4.

[New and traditional directions in the biology and management of childhood acute lymphoblastic leukemia].

Egyed B, Kovács G, Kutszegi N, Rzepiel A, Csányiné Sági J, Erdélyi DJ, Müller J, Félné Semsei Á.

Orv Hetil. 2018 May;159(20):786-797. doi: 10.1556/650.2018.31059. Review. Hungarian.

PMID:
29754509
5.

HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia.

Kutszegi N, Yang X, Gézsi A, Schermann G, Erdélyi DJ, Semsei ÁF, Gábor KM, Sági JC, Kovács GT, Falus A, Zhang H, Szalai C.

Haematologica. 2017 Sep;102(9):1578-1586. doi: 10.3324/haematol.2017.168211. Epub 2017 Jun 8.

6.

Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.

Farkas T, Müller J, Erdelyi DJ, Csoka M, Kovacs GT.

Pathol Oncol Res. 2017 Oct;23(4):889-897. doi: 10.1007/s12253-017-0192-8. Epub 2017 Jan 30.

7.

[Extracellular vesicles and their role in hematological malignancies].

Rzepiel A, Kutszegi N, Cs Sági J, Kelemen A, Pálóczi K, F Semsei Á, Buzás E, Erdélyi DJ.

Orv Hetil. 2016 Aug;157(35):1379-84. doi: 10.1556/650.2016.30532. Review. Hungarian.

PMID:
27569460
8.

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.

Hegyi M, Arany A, Semsei AF, Csordas K, Eipel O, Gezsi A, Kutszegi N, Csoka M, Muller J, Erdelyi DJ, Antal P, Szalai C, Kovacs GT.

Oncotarget. 2017 Feb 7;8(6):9388-9398. doi: 10.18632/oncotarget.11543.

9.

Pharmacogenetics of anthracyclines.

Sági JC, Kutszegi N, Kelemen A, Fodor LE, Gézsi A, Kovács GT, Erdélyi DJ, Szalai C, Semsei ÁF.

Pharmacogenomics. 2016 Jun;17(9):1075-87. doi: 10.2217/pgs-2016-0036. Epub 2016 Jun 8. Review.

PMID:
27266419
10.

Some GCR Polymorphisms (N363S, ER22/23EK, and Bcl-1) May Influence Steroid-induced Toxicities and Survival Rates in Children With ALL.

Eipel O, Hegyi M, Csordás K, Németh K, Luczay A, Török D, Csóka M, Erdélyi D, Kovács G.

J Pediatr Hematol Oncol. 2016 Jul;38(5):334-40. doi: 10.1097/MPH.0000000000000535.

PMID:
27050122
11.

Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity.

Kutszegi N, Semsei ÁF, Gézsi A, Sági JC, Nagy V, Csordás K, Jakab Z, Lautner-Csorba O, Gábor KM, Kovács GT, Erdélyi DJ, Szalai C.

PLoS One. 2015 Oct 12;10(10):e0140136. doi: 10.1371/journal.pone.0140136. eCollection 2015.

12.

Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia.

Gabor KM, Schermann G, Lautner-Csorba O, Rarosi F, Erdelyi DJ, Endreffy E, Berek K, Bartyik K, Bereczki C, Szalai C, Semsei AF.

Pediatr Blood Cancer. 2015 Apr;62(4):622-8. doi: 10.1002/pbc.25379. Epub 2015 Jan 3.

PMID:
25557962
13.

Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.

Csordas K, Lautner-Csorba O, Semsei AF, Harnos A, Hegyi M, Erdelyi DJ, Eipel OT, Szalai C, Kovacs GT.

Br J Haematol. 2014 Aug;166(3):410-20. doi: 10.1111/bjh.12886. Epub 2014 Apr 9.

PMID:
24712521
14.

[Flow cytometry in the diagnosis of hemophagocytic lymphohistiocytosis in a case with fatal outcome].

Pállinger E, Erdélyi D, Kovács G, Kriván G, Korponay Z, Fekete G, Szabó A, Falus A, Dérfalvi B.

Orv Hetil. 2014 Mar 9;155(10):389-95. doi: 10.1556/OH.2014.29790. Hungarian.

PMID:
24583560
15.

Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis.

Lautner-Csorba O, Gézsi A, Erdélyi DJ, Hullám G, Antal P, Semsei ÁF, Kutszegi N, Kovács G, Falus A, Szalai C.

PLoS One. 2013 Aug 5;8(8):e69843. doi: 10.1371/journal.pone.0069843. Print 2013.

16.

[Examination of late pulmonary toxicity in children treated for malignancies].

Jordán Z, Tokodi Z, Németh A, Müller J, Csóka M, Mohl A, Erdélyi D, Kovács G.

Orv Hetil. 2013 Mar 3;154(9):345-50. doi: 10.1556/OH.2013.29549. Hungarian.

PMID:
23434884
17.

Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.

Csordas K, Hegyi M, Eipel OT, Muller J, Erdelyi DJ, Kovacs GT.

Anticancer Drugs. 2013 Feb;24(2):189-97. doi: 10.1097/CAD.0b013e32835b8662.

PMID:
23187460
18.

Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance.

Lautner-Csorba O, Gézsi A, Semsei AF, Antal P, Erdélyi DJ, Schermann G, Kutszegi N, Csordás K, Hegyi M, Kovács G, Falus A, Szalai C.

BMC Med Genomics. 2012 Sep 28;5:42. doi: 10.1186/1755-8794-5-42.

19.

Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma.

Hegyi M, Gulácsi A, Cságoly E, Csordás K, Eipel OT, Erdélyi DJ, Müller J, Nemes K, Lautner-Csorba O, Kovács GT.

J Cancer Res Clin Oncol. 2012 Oct;138(10):1697-702. Epub 2012 Jun 1.

PMID:
22652833
20.

ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia.

Semsei AF, Erdelyi DJ, Ungvari I, Csagoly E, Hegyi MZ, Kiszel PS, Lautner-Csorba O, Szabolcs J, Masat P, Fekete G, Falus A, Szalai C, Kovacs GT.

Cell Biol Int. 2012 Jan;36(1):79-86. doi: 10.1042/CBI20110264.

PMID:
21929509

Supplemental Content

Loading ...
Support Center